BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29325525)

  • 1. Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries.
    Ahmad AA; Falla AM; Duffell E; Noori T; Bechini A; Reintjes R; Veldhuijzen IK
    BMC Infect Dis; 2018 Jan; 18(1):34. PubMed ID: 29325525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.
    Falla AM; Ahmad AA; Duffell E; Noori T; Veldhuijzen IK
    BMC Infect Dis; 2018 Jan; 18(1):42. PubMed ID: 29338702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review.
    Hofstraat SHI; Falla AM; Duffell EF; Hahné SJM; Amato-Gauci AJ; Veldhuijzen IK; Tavoschi L
    Epidemiol Infect; 2017 Oct; 145(14):2873-2885. PubMed ID: 28891457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study.
    Trickey A; Bivegete S; Duffell E; McNaughton AL; Nerlander L; Walker JG; Fraser H; Hickman M; Vickerman P; Brooks-Pollock E; Christensen H
    BMC Infect Dis; 2023 Jul; 23(1):457. PubMed ID: 37430220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review.
    Myran DT; Morton R; Biggs BA; Veldhuijzen I; Castelli F; Tran A; Staub LP; Agbata E; Rahman P; Pareek M; Noori T; Pottie K
    Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30200406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles among migrants in the European Union and the European Economic Area.
    Williams GA; Bacci S; Shadwick R; Tillmann T; Rechel B; Noori T; Suk JE; Odone A; Ingleby JD; Mladovsky P; Mckee M
    Scand J Public Health; 2016 Feb; 44(1):6-13. PubMed ID: 26563254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review.
    Bivegete S; McNaughton AL; Trickey A; Thornton Z; Scanlan B; Lim AG; Nerlander L; Fraser H; Walker JG; Hickman M; Vickerman P; Johnson H; Duffell E; Brooks-Pollock E; Christensen H
    Euro Surveill; 2023 Jul; 28(30):. PubMed ID: 37498533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions to Improve Vaccination Uptake and Cost Effectiveness of Vaccination Strategies in Newly Arrived Migrants in the EU/EEA: A Systematic Review.
    Hui C; Dunn J; Morton R; Staub LP; Tran A; Hargreaves S; Greenaway C; Biggs BA; Christensen R; Pottie K
    Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30241320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA.
    Deblonde J; Sasse A; Del Amo J; Burns F; Delpech V; Cowan S; Levoy M; Keith L; Pharris A; Amato-Gauci A; Noori T
    BMC Public Health; 2015 Dec; 15():1228. PubMed ID: 26654427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
    Aspinall EJ; Hutchinson SJ; Goldberg DJ; Valerio H; Mozalevskis A; Noori T; Duffell E; Tavoschi L
    HIV Med; 2018 Feb; 19 Suppl 1():11-15. PubMed ID: 29488708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review.
    Greenaway C; Makarenko I; Chakra CNA; Alabdulkarim B; Christensen R; Palayew A; Tran A; Staub L; Pareek M; Meerpohl JJ; Noori T; Veldhuijzen I; Pottie K; Castelli F; Morton RL
    Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30223539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missed hepatitis b/c or syphilis diagnosis among Kurdish, Russian, and Somali origin migrants in Finland: linking a population-based survey to the national infectious disease register.
    Tiittala P; Ristola M; Liitsola K; Ollgren J; Koponen P; Surcel HM; Hiltunen-Back E; Davidkin I; Kivelä P
    BMC Infect Dis; 2018 Mar; 18(1):137. PubMed ID: 29558910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
    Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
    BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013.
    Ködmön C; Zucs P; van der Werf MJ
    Euro Surveill; 2016; 21(12):. PubMed ID: 27039665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe.
    Ozaras R; Corti G; Ruta S; Lacombe K; Mondelli MU; Irwing WL; Puoti M; Khalighi A; Santos ML; Harxhi A; Lazarevic I; Soriano V; Gervain J; Leblebicioglu H; Salmon D; Arends JE;
    Clin Microbiol Infect; 2015 Nov; 21(11):1027-32. PubMed ID: 26166544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis B genotype E in African migrants: response to nucleos(t)ide treatment in real clinical practice.
    Cuenca-Gómez JÁ; Lozano-Serrano AB; Cabezas-Fernández MT; Soriano-Pérez MJ; Vázquez-Villegas J; Estévez-Escobar M; Cabeza-Barrera I; Salas-Coronas J
    BMC Infect Dis; 2018 Nov; 18(1):568. PubMed ID: 30428845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European policies in the management of tuberculosis among migrants.
    D'Ambrosio L; Centis R; Dara M; Solovic I; Sulis G; Zumla A; Migliori GB
    Int J Infect Dis; 2017 Mar; 56():85-89. PubMed ID: 27836793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and Genotyping of Patients with Chronic Hepatitis B: Genotype Shifting Observed in Patients from Central Europe.
    Bissinger AL; Fehrle C; Werner CR; Lauer UM; Malek NP; Berg CP
    Pol J Microbiol; 2015; 64(1):15-21. PubMed ID: 26094311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cultural and linguistic diversity of people living with chronic hepatitis B in 2011-2016: changing migration, shifting epidemiology.
    MacLachlan JH; Cowie BC
    Aust N Z J Public Health; 2018 Oct; 42(5):441-443. PubMed ID: 30198602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results.
    Kunst H; Burman M; Arnesen TM; Fiebig L; Hergens MP; Kalkouni O; Klinkenberg E; Orcau À; Soini H; Sotgiu G; Zenner D; de Vries G
    Int J Tuberc Lung Dis; 2017 Aug; 21(8):840-851. PubMed ID: 28786791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.